Conavi Medical Expands Leadership Team
Conavi Medical, a company focused on imaging tech to guide minimally invasive cardiovascular procedures, has revealed strategic leadership changes related to its planned commercial launch and expansion in the U.S.
The company submitted its next-gen Novasight Hybrid IVUS/OCT intravascular imaging system to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. It’s building the infrastructure needed for a successful U.S. launch.
Conavi appointed Mark Quick as chief financial officer (CFO). He will oversee financial strategy and investor engagement as the company prepares for U.S. launch.
Quick boasts over two decades of experience in the medtech and life sciences sectors. Before joining Conavi, he held senior financial leadership positions with publicly traded companies on Nasdaq. Earlier in his career, Quick was a sell-side equity research analyst at Canaccord Genuity, where he covered the medical device industry.
